A phase I study of hepatic arterial infusion using difluoromethylornithine

No abstract is available for this paper.

• Publication year

  1989

• Venue

  Cancer

• Publication date

  1989-02-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1002/1097-0142(19890201)63:3<433::AID-CNCR2820630306>3.0.CO;2-5PMID 2492203
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Polyamines in Mammalian Biology and Medicine

  2015cited by this paper
• Phase I evaluation of intravenous difluoromethylornithine — a polyamine inhibitor

  2004cited by this paper
• Phase II trials of alpha-difluoromethylornithine, an inhibitor of polyamine synthesis, in advanced small cell lung cancer and colon cancer.

  1986cited by this paper
• A phase II study of alpha-difluoromethylornithine (DFMO) for the treatment of metastatic melanoma.

  1986cited by this paper
• Polyamines in biology and medicine.

  1985cited by this paper
• Phase I trial and pharmacokinetic studies of alpha-difluoromethylornithine--an inhibitor of polyamine biosynthesis.

  1984cited by this paper
• Hepatic arterial chemotherapy for colorectal cancer metastatic to the liver.

  1984cited by this paper
• Successful treatment with dl-alpha-difluoromethyl ornithine (dfmo) of established human small cell lung carcinoma implants in athymic mice. Abstr.

  1983cited by this paper
• Effects of α-Difluoromethylornithine and 5-Fluorouracil on the Proliferation of a Human Colon Adenocarcinoma Cell Line

  1983cited by this paper
• Polyamines in mammalian tumors. Part II.

  1982cited by this paper
• Polyamine metabolism and function.

  1982cited by this paper
• Suicide enzyme inhibitors as potential drugs

  1981cited by this paper
• Polyamines in mammalian tumors. Part I.

  1981cited by this paper
• Polyamines are necessary for the survival of human small-cell lung carcinoma in culture.

  1981cited by this paper
• Role of polyamines in the control of cell proliferation and differentiation.

  1981cited by this paper
• Inhibition of polyamine biosynthesis by alpha-difluoromethyl ornithine potentiates the cytotoxic effects of arabinosyl cytosine in HeLa cells.

  1980cited by this paper
• Inhibition of EMT6 tumor growth by interference with polyamine biosynthesis; effects of alpha-difluoromethylornithine, an irreversible inhibitor of ornithine decarboxylase.

  1980cited by this paper
• Suppression of the formation of polyamines and macromolecules by DL-alpha-difluoromethylornithine and methylglyoxal bis(guanylhydrazone) in phytohaemagglutinin-activated human lymphocytes.

  1979cited by this paper
• Isotopically selective CO/sub 2/ transverse excitation laser induced chemical reactions of Cl/sub 2/CF/sub 2/ and Br/sub 2/CF/sub 2/ with olefins

  1978cited by this paper
• A clinical-pharmacological evaluation of hepatic arterial infusions of 5-fluoro-2'-deoxyuridine and 5-fluorouracil.

  1978cited by this paper
• Polyamines in rapid growth and cancer.

  1978cited by this paper
• Effect of alpha-difluoromethylornithine, an enzyme-activated irreversible inhibitor of ornithine decarboxylase, on L1210 leukemia in mice.

  1978cited by this paper
• Catalytic irreversible inhibition of mammalian ornithine decarboxylase (E.C.4.1.1.17) by substrate and product analogs

  1978cited by this paper
• Anti-proliferative properties of DL-alpha-difluoromethyl ornithine in cultured cells. A consequence of the irreversible inhibition of ornithine decarboxylase.

  1978cited by this paper

• Pharmacological properties of the ornithine decarboxylase inhibitor 3-aminooxy-1-propanamine and several structural analogues

  2004cites this paper
• Recommendations for cancer prevention trials using potentially ototoxic test agents.

  2001cites this paper
• Effects of methylacetylenic putrescine, an ornithine decarboxylase inhibitor and potential novel anticancer agent, on human and mouse cancer cell lines.

  1999cites this paper
• α-Difluoromethylornithine Ototoxicity: Chemoprevention Clinical Trial Results

  1997cites this paper
• alpha-difluoromethylornithine ototoxicity. Chemoprevention clinical trial results.

  1997cites this paper
• Toxicity evaluation of difluoromethylornithine: doses for chemoprevention trials.

  1996cites this paper
• Derivatives of 1-aminooxy-3-aminopropane as polyamine antimetabolites: stability and effects on BHK21/C13 cells.

  1994cites this paper
• Ototoxicity of chemotherapeutic agents.

  1993cites this paper
• The role of dietary polyamines.

  1993cites this paper
• Polyamines: from molecular biology to clinical applications.

  1991cites this paper